Johnson and Johnson recalls Tylenol produced at shuttered plant

A Tylenol recall has been declared for merchandise produced at a McNeil Consumer Healthcare plant by its parent company, Johnson and Johnson. Monday’s announcement marks the fifth time this year the company has been forced to respond drastically to consumer grievances, and comes while the drug maker is under congressional investigation for negligent quality manage practices. A moldy smell coming from the containers triggered the latest recall of the popular over-the-counter medicine.

Recall of Tylenol 8-hour products

The Tylenol recall had been talked about Monday. That was the latest news on it. Johnson and Johnson’s McNeil Consumer Healthcare division voluntarily removed about 128,000 bottles of 50-count Tylenol 8-Hour Caplets. Based on the New York Times, the recall had been started by McNeil due to a “musty or moldy odor” within the Tylenol 8-Hour. This had been a complaint with United States and Puerto Rico products. Before March, when the Fort Washington, Pa., plant had been closed, it made the batch of Tylenol the business is now recalling. The cause of the recall is the same excuse for why there had been a Tylenol recall in January, June and July with goods produced in Puerto Rico at the McNeil plant. They said a chemical used to treat wooden transport pallets that leached to the Tylenol probably caused there to be a musty smell.

Tylenol just keeps recalling

A congressional inquiry has been going into Johnson and Johnson. This is because there are various recalls just this year. CNN accounts that last Nov, five lots of 100-count Tylenol Arthritis Pain were recalled for a stench causing nausea, stomach pain, vomiting and diarrhea. Then in December, there had been another recall. This recalled of the lots. The recall was then expanded even further to non-prescription drugs causing odor and nausea with things for instance Tylenol and Motrin. Quality manage and safety concerns brought on 50 children’s medicines to be within the recall in May.

Not controlling things well

The McNeil plant had been closed by Johnson and Johnson. This was done in April. According to Reuters, Johnson and Johnson is revamping all of the level of quality manage plans within the plant. This is so the violations found by the United States of America Food and drug administration could be fixed. Based on the FDA, the plant had contaminated drug ingredients. There was also dust and grime everywhere. Johnson and Johnson’s bottom line got about $650 million a year just from the drugs manufactured at the Fort Washington plant. The company will make about $600 billion less this year due to recalls and factory closings, claims Bloomberg.

Articles cited

New York Times

prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss

CNN

cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1

Reuters

reuters.com/article/idUSTRE69I2W320101019